A Single Dose Bioequivalence Study Comparing the Commercial Tablet Formulation to the Clinical Tablet of Bosutinib in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Bosutinib (Primary)
- Indications Acute lymphoblastic leukaemia; Breast cancer; Chronic myeloid leukaemia; Solid tumours
- Focus Pharmacokinetics
- Sponsors Wyeth
- 03 Sep 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Sep 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 New trial record